Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Granulomatous lung disease requiring mechanical ventilation induced by a single application of oxaliplatin-based chemotherapy for colorectal cancer: a case report.
Wildner D, Boxberger F, Wein A, Wolff K, Albrecht H, Männlein G, Janka R, Amann K, Siebler J, Hohenberger W, Neurath MF, Strauß R. Wildner D, et al. Among authors: wolff k. Case Rep Oncol Med. 2013;2013:683948. doi: 10.1155/2013/683948. Epub 2013 Apr 8. Case Rep Oncol Med. 2013. PMID: 23691384 Free PMC article.
Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial.
Wolff K, Wein A, Reulbach U, Männlein G, Brückl V, Meier C, Ostermeier N, Schwab SA, Horbach T, Hohenberger W, Hahn EG, Boxberger F. Wolff K, et al. Anticancer Drugs. 2009 Mar;20(3):165-73. doi: 10.1097/CAD.0b013e32831f8ec9. Anticancer Drugs. 2009. PMID: 19125117 Clinical Trial.
Palliative first-line therapy with weekly high-dose 5-fluorouracil and sodium folinic acid as a 24-hour infusion (AIO regimen) combined with weekly irinotecan in patients with metastatic adenocarcinoma of the stomach or esophagogastric junction followed by secondary metastatic resection after downsizing.
Koucky K, Wein A, Konturek PC, Albrecht H, Reulbach U, Männlein G, Wolff K, Ostermeier N, Busse D, Golcher H, Schildberg C, Janka R, Hohenberger W, Hahn EG, Siebler J, Neurath MF, Boxberger F. Koucky K, et al. Among authors: wolff k. Med Sci Monit. 2011 May;17(5):CR248-58. doi: 10.12659/msm.881764. Med Sci Monit. 2011. PMID: 21525806 Free PMC article.
Successful Multidisciplinary Treatment with Secondary Metastatic Liver Resection after Downsizing by Palliative Second-Line Treatment of Colorectal Cancer: A Curative Option.
Wein A, Siebler J, Goertz R, Wolff K, Ostermeier N, Busse D, Kremer AE, Koch F, Hagel A, Farnbacher M, Kammerer FJ, Neurath MF, Gruetzmann R. Wein A, et al. Among authors: wolff k. Case Rep Oncol. 2016 Jul 9;9(2):379-86. doi: 10.1159/000445677. eCollection 2016 May-Aug. Case Rep Oncol. 2016. PMID: 27489542 Free PMC article.
Weekly High-dose 5-Fluorouracil as 24-hour Infusion Combined with Sodium Folinic Acid (AIO regimen) Plus Irinotecan in Second-line and Sequential Therapy of Metastatic Colorectal Cancer (CRC).
Wein A, Siebler J, Wolff K, Ostermeier N, Busse D, Hagel A, Koch F, Merx K, Neurath MF, Hofheinz RD. Wein A, et al. Among authors: wolff k. Anticancer Res. 2017 Jul;37(7):3771-3779. doi: 10.21873/anticanres.11752. Anticancer Res. 2017. PMID: 28668873 Clinical Trial.
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents.
Dürr P, Schlichtig K, Kelz C, Deutsch B, Maas R, Eckart MJ, Wilke J, Wagner H, Wolff K, Preuß C, Brückl V, Meidenbauer N, Staerk C, Mayr A, Fietkau R, Goebell PJ, Kunath F, Beckmann MW, Mackensen A, Neurath MF, Pavel M, Dörje F, Fromm MF. Dürr P, et al. Among authors: wolff k. J Clin Oncol. 2021 Jun 20;39(18):1983-1994. doi: 10.1200/JCO.20.03088. Epub 2021 Apr 6. J Clin Oncol. 2021. PMID: 33822650 Clinical Trial.
A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results.
Wein A, Stoehr R, Kersting S, Siebler J, Merkel S, Busse D, Wolff K, Ostermeier N, Neufert C, Vitali F, Eckstein M, Roth JP, Anhut P, Schreiner W, Uder M, Hartmann A, Neurath MF, Grützmann R. Wein A, et al. Among authors: wolff k. Oncology. 2022;100(1):1-11. doi: 10.1159/000519252. Epub 2021 Oct 20. Oncology. 2022. PMID: 34670215 Clinical Trial.
CD71 expressing circulating neutrophils serve as a novel prognostic biomarker for metastatic spread and reduced outcome in pancreatic ductal adenocarcinoma patients.
Hansen FJ, Mittelstädt A, Clausen FN, Knoedler S, Knoedler L, Klöckner S, Kuchenreuther I, Mazurie J, Arnold LS, Anthuber A, Jacobsen A, Merkel S, Weisel N, Klösch B, Karabiber A, Tacyildiz I, Czubayko F, Reitberger H, Gendy AE, Brunner M, Krautz C, Wolff K, Mihai S, Neufert C, Siebler J, Grützmann R, Weber GF, David P. Hansen FJ, et al. Among authors: wolff k. Sci Rep. 2024 Sep 10;14(1):21164. doi: 10.1038/s41598-024-70916-3. Sci Rep. 2024. PMID: 39256468 Free PMC article.
1,174 results